INVESTIGATING THE DRUGGABILITY LANDSCAPE OF EMBRYONAL RHABDOMYOSARCOMA (ERMS) USING A PRECLINICAL RECURRENCE MODEL

by LEUNG JIA YU
Published 2024

Interweaving Tumor Heterogeneity into the Cancer Epigenetic-Metabolic Axis

by Leung, Jia Yu, CHIA KIMBERLY, ONG SEK TONG, DERRICK, RESHMA TANEJA
Published 2019

BRD4 isoforms have distinct roles in tumour progression and metastasis in rhabdomyosarcoma.

by Das, Dipanwita, Leung, Jia Yu, Balamurugan, Shivaranjani, Tergaonkar, Vinay, Loh, Amos Hong Pheng, Chiang, Cheng-Ming, Taneja, Reshma
Published 2024

EHMT2 epigenetically suppresses Wnt signaling and is a potential target in embryonal rhabdomyosarcoma

by Pal, Ananya, Leung, Jia Yu, Ang, Gareth Chin Khye, Rao, Vinay Kumar, Pignata, Luca, Lim, Huey Jin, Hebrard, Maxime, Chang, Kenneth TE, Lee, Victor KM, Guccione, Ernesto, Taneja, Reshma
Published 2020

Regulation of the NRF2 transcription factor by andrographolide and organic extracts from plant endophytes

by Wong, Daphne Pei Wen, Ng, Mei Ying, Leung, Jia Yu, Boh, Boon Kim, Lim, Ee Chien, Tan, Shi Hua, Lim, Shuying, Seah, Wen Hui, Hu, Christine Zhiwen, Ho, Boon Chuan, Ng, Daphne Hui Ping, Hagen, Thilo
Published 2019